BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 3.3% of their position (1.42K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $132.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001197350-26-000001
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
-1.42K
Net shares
Net seller
$132.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.33K acquired · 4.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.33K
Price / share
—
Trade value
—
% of position
8.3%
1/21/2026
40.21K→43.55K
Common Stock
Direct
Shares
−1.42K
Price / share
$93.33
Trade value
$132.62K
% of position
3.3%
1/22/2026
43.55K→42.13K
Total
Net shares
+1.91K
Net value
-$132.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | M · Option Exercise | +3.33K | — | — | 8.3% | 40.21K | 43.55K |
| Common Stock Direct | 1/22/2026 | S · Sale | −1.42K | $93.33 | $132.62K | 3.3% | 43.55K | 42.13K |
| Total | +1.91K | -$132.62K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
Held after
6.67K
Exercisable
—
1/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.33K shares | 1/21/2026 | M · Option Exercise | −3.33K | — | 6.67K |